

第1页 / 共14页
试读已结束,还剩13页,您可下载完整版后进行离线阅读
THE END
中华心力衰竭和心肌病杂志2020年9月第4卷第3期Chin J Heart Fail&Cardiomyopathy,September2020.Vol.4,No.3…145指南与共识.经皮机械循环辅助临床应用及管理中国专家共识中国医师协会心力衰竭专业委员会国家心血管病专家委员会心力衰竭专业委员会中华心力衰竭和心肌病杂志编辑委员会共同通信作者:周胜华,Email:zhoushenghua@csu.edu.cn;高传玉,Email:gaocye6802@l63.com;杨伟宪,Email:wxyang2009@sina.com;张宇辉,Email:yuhuizhangjoy@l63.com【摘要】经皮机械循环辅助(pMCS)是体外生命支持的重要手段之一。为指导临床应用pMCS,本委员会基于国内外相关指南与循证医学证据,结合我国实际情况,制定本共识,将就MS的常用装置、工作原理、临床应用、装置选择、置入与撤离时机和应用管理等几个方面进行介绍,以推动♪MCS技术的规范化应用。【关键词】经皮机械循环辅助:临床应用:适应证:应用管理D0L:10.3760/emaj.cm101460-20200812-00078Chinese Expert Consensus on Clinical Application and Management of Percutaneous MechanicalCirculatory SupportChinese Heart Failure Association of Chinese Medical Doctor Association,National Expert Committee onCardiovascular Diseases and Professional Committee on Heart Failure,Editorial Board of Chinese Journal ofHeart Failure and CardiomyopathyCo-corresponding authors:Zhou Shenghua,Emaik zhoushenghua@csu.edu.cn;Gao Chuanyu,Email:gaocy6802@163.com;Yang Weixian,Email:wxyang2009@sina.com;Zhang Yuhui,Email:yuhuizhangjoy@163.com[Abstract Percutaneous mechanical circulatory support (pMCS)is one of the important means ofextracorporeal life support.In order to guide clinical application of pMCS,the committee formulated thisconsensus based on the relevant guidelines and evidence-based medicine evidences at home and aboard inlight of the actual situation in China,focusing on the device introduction,working principle,clinicalapplication,device selection,timing of implantation and withdrawal,and application management of pMCS,so as to promote the standardized application of pMCS in clinical practice.[Key words Mechanical circulatory support,percutaneous:Clinical application;Indication;Application managementD0L:10.3760 Wcma.j.cm101460-20200812-00078机械循环辅助(mechanical circulatory support,数据s,截至2019年全球已有112231名患者接受MCS)是一种生命支持技术,在20世纪50年代首先了体外生命支持(extracorporeal life support,被应用于临床,经过60年的发展,现在已经成为心ECLS),其中接受MCS的患者大部分采用pMCS。脏急性事件及终末期心力衰竭(心衰)等患者的重近年来,pMCS在我国的应用快速发展,能够开展要“桥梁”治疗。pMCS的中心数量和辅助例数逐年增长,技术也在经皮机械循环辅助(percutaneous mechanical逐渐完善6。据不完全统计,2019年我国约开展circulatory support,pMCS)是MCS的重要技术之主动脉内球囊反搏(intm-aortic balloon pump,一,近年来发展迅速4。根据体外生命支持组织IABP)26000例,开展体外膜肺氧合(extracorporeal(extracorporeal life support organization,ELSO)membrane oxygenation,ECMO)3700例,并有少数●“手5◆业留资0ZxvdWRWZXzaw9uL0o7
请登录后查看评论内容